Manager × security

Q Global Advisors, LLC ASND holdings history

ASCENDIS PHARMA A/S · CUSIP 04351P101 · CIK 1469589

Some filings reported values in thousands; those figures were scaled ×1000 to dollars.
This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2025-12-31, Q Global Advisors, LLC reported 190.00K ASND (shares), valued at $40.52M, or 39.86% of its reported non-derivative portfolio. Filed 2026-02-17.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
39.86%
Shares
190.00K
190,000
Reported value
$40.52M
USD

Shares increased 11.76%; reported value increased 19.88%, and weight changed -13.23 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 2026Not reportedNot reported—
Q1 2026Not reportedNot reported—
Q4 202539.86%190,000SEC filing ↗Filed Feb 17, 2026
Q3 202553.09%170,000SEC filing ↗Filed Nov 13, 2025
Q2 202537.03%255,000SEC filing ↗Filed Aug 14, 2025
Q1 202531.55%248,887SEC filing ↗Filed May 14, 2025
Q4 202431.14%219,459SEC filing ↗Filed Feb 24, 2025Amended
Q3 202428.82%219,459SEC filing ↗Filed Nov 12, 2024
Q2 202421.23%219,459SEC filing ↗Filed Aug 14, 2024
Q1 202416.34%285,000SEC filing ↗Filed May 15, 2024
Q4 202327.20%285,000SEC filing ↗Filed Feb 13, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 202327.20%285,000$35.90MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 13, 2024
Q1 202416.34%285,000$43.08MShares unchanged; reported value increased 20.02%, and weight changed -10.86 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 202421.23%219,459$29.93MShares decreased 23.00%; reported value decreased 30.53%, and weight changed +4.89 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 202428.82%219,459$32.77MShares unchanged; reported value increased 9.48%, and weight changed +7.59 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 12, 2024
Q4 202431.14%219,459$30.21MShares unchanged; reported value decreased 7.79%, and weight changed +2.32 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 24, 2025
Q1 202531.55%248,887$38.79MShares increased 13.41%; reported value increased 28.40%, and weight changed +0.41 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2025
Q2 202537.03%255,000$44.01MShares increased 2.46%; reported value increased 13.46%, and weight changed +5.48 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 202553.09%170,000$33.80MShares decreased 33.33%; reported value decreased 23.21%, and weight changed +16.06 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2025
Q4 202539.86%190,000$40.52MShares increased 11.76%; reported value increased 19.88%, and weight changed -13.23 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 2026Not reported——This security is absent from this quarter's filing; a missing record is not treated as zero holdings.—
Q2 2026Not reported——This security is absent from this quarter's filing; a missing record is not treated as zero holdings.—
Q Global Advisors, LLC · ASCENDIS PHARMA A/S

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1469589","quarter":"2026Q2","cusip":"04351P101"}

get_institutional_manager_history
{"cik":"1469589","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.